APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds | News | APMA
APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds

APMA Comments to CMS on NCD for Autologous Blood-Derived Products for Chronic Non-Healing Wounds Members Only Content

APMA recommended deleting the language in the NCD stating autologous PRP is non-covered when used for the treatment of “chronic, non-healing, cutaneous wounds.”

This content is available to APMA members only. If you are a member, please log in to see the full content.



Related Resources

Significant Changes to Steroid HCPCS Coding

Learn More

Skin Substitute Coverage Proposals Released

Learn More

ADVERTISEMENT
Be an advocate for your profession in five minutes or less. Log on today.